ScinoPharm Taiwan Ltd
Yanfei F. is an accomplished executive with extensive experience in corporate development and business strategy within the pharmaceutical and biotechnology sectors. Currently serving as the Head of Corporate Development at ScinoPharm Taiwan Ltd since October 2024, Yanfei has previously held significant leadership roles including Chief Business Development Officer at Recbio, Managing Director at LYFE Capital, and Senior Vice President of Business Development at Eddingpharm. Additionally, Yanfei founded and served as CEO of Diabetes Management Digital Solutions 微糖 from April 2012 to July 2019. Yanfei holds an MBA in Entrepreneurship, Finance, and Strategy from The University of Chicago Booth School of Business and a Master of Science in Neuroscience from the University of Iowa.
This person is not in any teams
This person is not in any offices
ScinoPharm Taiwan Ltd
ScinoPharm Taiwan, Ltd. is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of bulk drugs. The Company's products include anastrozole, galantamine hydrobromide, azacitidine, gemcitabine hydrochloride, benazepril hydrochloride, granisetron hydrochloride, bimatoprost, irinotecan hydrochloride, letrozole, capecitabine, omeprazole, cladribine, ondansetron hydrochloride, dantrolene sodium, oxandrolone, oecitabine, paclitaxel and desmopressin acetate. The Company provides drug development service, chemical process development service, analytical chemistry service, current good manufacturing practice (cGMP) manufacturing service and other related technical services. The Company distributes its products within domestic market and to overseas markets.